Mark Purcell Stock Analyst Profile - Morgan Stanley Research Coverage - Stocknear

Mark Purcell

Stock Analyst at Morgan Stanley

(3.28)
# 2769
Out of 5,477 analysts
6
Total ratings
Success rate
Average return
Main Sectors:
5 Stocks
Name Action PT Current % Upside Ratings Updated
SNY Sanofi
Upgrades: Overweight
56 58
47.42 22.31% 2 Sep 8, 2025
NVS Novartis
Initiates Coverage On: Equal-Weight
114
127.56 -10.63% 1 Jan 23, 2024
GSK GSK
Initiates Coverage On: Equal-Weight
44
41.37 6.36% 1 Jan 23, 2024
AZN AstraZeneca
Initiates Coverage On: Overweight
85
81.01 4.93% 1 Jan 23, 2024
NVO Novo Nordisk
Initiates Coverage On: Overweight
120
53.99 122.26% 1 Jan 23, 2024